Short telomere length is implicated in lung diseases and can be caused by mutations in telomere genes. Acquired autoimmunity directed against components of the telomere system is now reported in some patients with systemic sclerosis or idiopathic pulmonary fibrosis, suggesting a novel explanation for short telomeres in these diseases.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Adler, B. L. et al. Autoantibodies targeting telomere-associated proteins in systemic sclerosis. Ann. Rheum. Dis. 80, 912–919 (2021).
Grill, S. & Nandakumar, J. Molecular mechanisms of telomere biology disorders. J. Biol. Chem. 296, 100064 (2020).
Stock, C. J. W. & Renzoni, E. A. Telomeres in interstitial lung disease. J. Clin. Med. 10, 1384 (2021).
Khanna, D. et al. Etiology, risk factors, and biomarkers in systemic sclerosis with interstitial lung disease. Am. J. Respir. Crit. Care. Med. 201, 650–660 (2020).
Silhan, L. L. et al. Lung transplantation in telomerase mutation carriers with pulmonary fibrosis. Eur. Respir. J. 44, 178–187 (2014).
Lakota, K. et al. Short lymphocyte, but not granulocyte, telomere length in a subset of patients with systemic sclerosis. Ann. Rheum. Dis. 78, 1142–1144 (2019).
Liu, T. et al. Telomerase and telomere length in pulmonary fibrosis. Am. J. Respir. Cell Mol. Biol 49, 260–268 (2013).
Weng, N. Interplay between telomere length and telomerase in human leukocyte differentiation and aging. J. Leukoc. Biol. 70, 861–867 (2001).
Razdan, N., Vasilopoulos, T. & Herbig, U. Telomere dysfunction promotes transdifferentiation of human fibroblasts into myofibroblasts. Aging Cell 17, e12838 (2018).
Newton, C. A. et al. Telomere length and use of immunosuppressive medications in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 200, 336–347 (2019).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Lakota, K., Varga, J. Linking autoimmunity, short telomeres and lung fibrosis in SSc. Nat Rev Rheumatol 17, 511–512 (2021). https://doi.org/10.1038/s41584-021-00666-3
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41584-021-00666-3